Medicine
Leukine 250 mcg/mL powder for injection
Leukine 250 mcg/mL powder for injection is a prescription medicine containing Sargramostim for intravenous, subcutaneous use, marketed by Partner Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store LEUKINE vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original…
Key facts
- Active ingredient (INN)
- Sargramostim
- Brand
- Leukine
- Strength
- 250 mcg/mL
- Dosage form
- Powder for injection
- Route
- Intravenous, subcutaneous
- Packs
- 5 vials
- Marketing authorisation holder
- Partner Therapeutics
- Manufacturer
- Partner Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store LEUKINE vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Do not freeze or shake.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L03AA09 Sargramostim
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 September 2023
- Identifiers
- RxCUI 208083, 315199DailyMed set ID bb9a3820-f31a-4dd9-bef4-97094c01a398NDC 71837-5843Application BLA103362
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 71837-5843-5 | Partner Therapeutics | 1 September 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Sargramostim is a leukocyte growth factor. It is available as powder for injection for intravenous and subcutaneous use. MedsAcross supplies Sargramostim for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SargramostimFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Leukine prescribing information (Partner Therapeutics) · U.S. National Library of Medicine, DailyMed
- Imreplys: European public assessment report (EPAR) · European Medicines Agency
Need Leukine 250 mcg/mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.